The import of penicillins or streptomycins in dosage forms to Brazil is forecasted to increase steadily from 2.85 million kilograms in 2024 to 3.19 million kilograms by 2028. As per the available data, import volumes were previously recorded but not available for 2023, suggesting a focus on recent trends. The year-on-year growth indicates a stable increase around 2-3% annually over the forecast period, reflecting a compounded annual growth rate (CAGR) slightly above 2.5% for 2024-2028.
Future trends to watch include potential shifts in demand due to antibiotic resistance management, changes in healthcare policies, and competition from emerging markets. Additionally, fluctuations in currency and global production might influence Brazil's import strategies for these pharmaceuticals.
